Zsuzsanna Csoma
Budapest, BU, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Managing multimorbidity in severe asthma: comparison of resources and perspectives between severe asthma specialists and general respiratory physicians across Europe.
Journal: ERJ open research
Published: February 17, 2026
Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study.
Journal: Journal of asthma and allergy
Published: February 10, 2026
Multimorbidity phenotypes and associated characteristics in severe asthma: an observational study of European severe asthma registries.
Journal: The Lancet regional health. Europe
Published: August 27, 2025
Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma Registry.
Journal: The Lancet. Respiratory medicine
Published: August 03, 2025
Alpha1-Antitrypsin in Lung Diseases: A Cross-Sectional Observational Study.
Journal: International journal of molecular sciences
Published: March 03, 2025
Economic impact of steroid-induced comorbidities in severe asthma: a SHARP CRC simulation.
Journal: ERJ open research
Published: January 31, 2025
Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR).
Journal: The World Allergy Organization journal
Published: December 18, 2024
Newly diagnosed eosinophilic granulomatosis with polyangiitis in patients on biologics for severe asthma: A multicenter case series.
Journal: The journal of allergy and clinical immunology. In practice
Published: November 20, 2024
Benralizumab Outcomes in Patients with Severe Eosinophilic Asthma Treated in Real-Life Settings: Results of the BREEZE Study in 5 Countries From Central Eastern Europe and Baltics.
Journal: Journal of asthma and allergy
Published: November 16, 2024
COVID-19 vaccination acceptance, safety and side-effects in European patients with severe asthma.
Journal: ERJ open research
Published: August 13, 2023
Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis.
Journal: ERJ open research
Published: January 03, 2023
Characteristics of severe asthma patients on biologics: a real-life European registry study.
Journal: ERJ open research
Published: November 02, 2022
Last Updated: 09/26/2026